Medical News

RSS
BCBSIL announces four new ACO agreements to improve patient care

BCBSIL announces four new ACO agreements to improve patient care

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

University of Birmingham researchers identify new way to tackle chronic diseases

University of Birmingham researchers identify new way to tackle chronic diseases

Cardio3 BioSciences reports absence of short term adverse events in first patient following NKG2D CAR T-cell infusion

Cardio3 BioSciences reports absence of short term adverse events in first patient following NKG2D CAR T-cell infusion

Rocket carrying Reinnervate's Alvetex Scaffold blasts into Space to find better treatments for bone loss

Rocket carrying Reinnervate's Alvetex Scaffold blasts into Space to find better treatments for bone loss

Mindfulness-based cognitive therapy could offer new treatment choice for people with recurrent depression

Mindfulness-based cognitive therapy could offer new treatment choice for people with recurrent depression

Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

BioReliance inks non-exclusive license agreement with QTS for proprietary B-CLEAR technology

BioReliance inks non-exclusive license agreement with QTS for proprietary B-CLEAR technology

Comfortable, compact, clever - CX23 microscope

Comfortable, compact, clever - CX23 microscope

GenVec, Laboratory of Malaria Immunology and Vaccinology sign research collaboration agreement

GenVec, Laboratory of Malaria Immunology and Vaccinology sign research collaboration agreement

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

NSM Insurance Group launches new IFD Insurance for Dentists program

NSM Insurance Group launches new IFD Insurance for Dentists program

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Data presented at AACR 2015 recognizes value of EKF PointMan technology for assessing lung cancer mutation status

Data presented at AACR 2015 recognizes value of EKF PointMan technology for assessing lung cancer mutation status

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

BrainStorm presents positive results from NurOwn phase 2a study in ALS at AAN annual meeting

BrainStorm presents positive results from NurOwn phase 2a study in ALS at AAN annual meeting

Cincinnati Children's pediatric allergist offers tips to combat allergies

Cincinnati Children's pediatric allergist offers tips to combat allergies

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Current challenges in tackling macular degeneration: an interview with Mark Ackermann, AMD Alliance International

Current challenges in tackling macular degeneration: an interview with Mark Ackermann, AMD Alliance International

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.